Proteomic analysis of exosomes isolated from body fluids has revealed upregulation of ITGB4. This finding suggests that ITGB4 may serve as a potential biomarker for prostate cancer progression and taxane resistance. This evidence concerns the gene ITGB4 and prostate cancer.